 | • レポートコード：MRC2-11QY09362 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己投与薬のグローバル市場について調査・分析したレポートです。種類別（注射薬、吸入薬、経皮吸収薬）市場規模、用途別（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己投与薬の競争状況、市場シェア ・世界の自己投与薬市場：種類別市場規模 2015年-2020年（注射薬、吸入薬、経皮吸収薬） ・世界の自己投与薬市場：種類別市場規模予測 2021年-2026年（注射薬、吸入薬、経皮吸収薬） ・世界の自己投与薬市場：用途別市場規模 2015年-2020年（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他） ・世界の自己投与薬市場：用途別市場規模予測 2021年-2026年（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他） ・北米の自己投与薬市場分析：米国、カナダ ・ヨーロッパの自己投与薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己投与薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己投与薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己投与薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Bristol-Myers Squibb、Novartis AG、Eli Lilly and Company、Gilead Sciences、Antares Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Self-administered Drugs Market
The global Self-administered Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Self-administered Drugs Scope and Market Size
Self-administered Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Self-administered Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Self-administered Drugs market is segmented into
Injectable Drugs
Inhaled Drugs
Transdermal Drugs
Segment by Application, the Self-administered Drugs market is segmented into
Cardiovascular Diseases
Diabetes
Osteoporosis
Pain Management
Hormone Replacement
Others
Regional and Country-level Analysis
The Self-administered Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Self-administered Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Self-administered Drugs Market Share Analysis
Self-administered Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Self-administered Drugs business, the date to enter into the Self-administered Drugs market, Self-administered Drugs product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Bristol-Myers Squibb
Novartis AG
Eli Lilly and Company
Gilead Sciences
Antares Pharma
…
1 Study Coverage
1.1 Self-administered Drugs Product Introduction
1.2 Market Segments
1.3 Key Self-administered Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Self-administered Drugs Market Size Growth Rate by Type
1.4.2 Injectable Drugs
1.4.3 Inhaled Drugs
1.4.4 Transdermal Drugs
1.5 Market by Application
1.5.1 Global Self-administered Drugs Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Diabetes
1.5.4 Osteoporosis
1.5.5 Pain Management
1.5.6 Hormone Replacement
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Self-administered Drugs Market Size, Estimates and Forecasts
2.1.1 Global Self-administered Drugs Revenue 2015-2026
2.1.2 Global Self-administered Drugs Sales 2015-2026
2.2 Global Self-administered Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Self-administered Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Self-administered Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Self-administered Drugs Competitor Landscape by Players
3.1 Self-administered Drugs Sales by Manufacturers
3.1.1 Self-administered Drugs Sales by Manufacturers (2015-2020)
3.1.2 Self-administered Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Self-administered Drugs Revenue by Manufacturers
3.2.1 Self-administered Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Self-administered Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Self-administered Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Self-administered Drugs Revenue in 2019
3.2.5 Global Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Self-administered Drugs Price by Manufacturers
3.4 Self-administered Drugs Manufacturing Base Distribution, Product Types
3.4.1 Self-administered Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Self-administered Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Self-administered Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Self-administered Drugs Market Size by Type (2015-2020)
4.1.1 Global Self-administered Drugs Sales by Type (2015-2020)
4.1.2 Global Self-administered Drugs Revenue by Type (2015-2020)
4.1.3 Self-administered Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Self-administered Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Self-administered Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Self-administered Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Self-administered Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Self-administered Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Self-administered Drugs Market Size by Application (2015-2020)
5.1.1 Global Self-administered Drugs Sales by Application (2015-2020)
5.1.2 Global Self-administered Drugs Revenue by Application (2015-2020)
5.1.3 Self-administered Drugs Price by Application (2015-2020)
5.2 Self-administered Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Self-administered Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Self-administered Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Self-administered Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Self-administered Drugs by Country
6.1.1 North America Self-administered Drugs Sales by Country
6.1.2 North America Self-administered Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Self-administered Drugs Market Facts & Figures by Type
6.3 North America Self-administered Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Self-administered Drugs by Country
7.1.1 Europe Self-administered Drugs Sales by Country
7.1.2 Europe Self-administered Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Self-administered Drugs Market Facts & Figures by Type
7.3 Europe Self-administered Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Self-administered Drugs by Region
8.1.1 Asia Pacific Self-administered Drugs Sales by Region
8.1.2 Asia Pacific Self-administered Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Self-administered Drugs Market Facts & Figures by Type
8.3 Asia Pacific Self-administered Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Self-administered Drugs by Country
9.1.1 Latin America Self-administered Drugs Sales by Country
9.1.2 Latin America Self-administered Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Self-administered Drugs Market Facts & Figures by Type
9.3 Central & South America Self-administered Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Self-administered Drugs by Country
10.1.1 Middle East and Africa Self-administered Drugs Sales by Country
10.1.2 Middle East and Africa Self-administered Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Self-administered Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Self-administered Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Self-administered Drugs Products Offered
11.1.5 Abbott Laboratories Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Self-administered Drugs Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG Self-administered Drugs Products Offered
11.3.5 Novartis AG Related Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Description and Business Overview
11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company Self-administered Drugs Products Offered
11.4.5 Eli Lilly and Company Related Developments
11.5 Gilead Sciences
11.5.1 Gilead Sciences Corporation Information
11.5.2 Gilead Sciences Description and Business Overview
11.5.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gilead Sciences Self-administered Drugs Products Offered
11.5.5 Gilead Sciences Related Developments
11.6 Antares Pharma
11.6.1 Antares Pharma Corporation Information
11.6.2 Antares Pharma Description and Business Overview
11.6.3 Antares Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Antares Pharma Self-administered Drugs Products Offered
11.6.5 Antares Pharma Related Developments
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Self-administered Drugs Products Offered
11.1.5 Abbott Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Self-administered Drugs Market Estimates and Projections by Region
12.1.1 Global Self-administered Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Self-administered Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Self-administered Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Self-administered Drugs Sales Forecast (2021-2026)
12.2.2 North America: Self-administered Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Self-administered Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Self-administered Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Self-administered Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Self-administered Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Self-administered Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Self-administered Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Self-administered Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Self-administered Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Self-administered Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Self-administered Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Self-administered Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Self-administered Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Self-administered Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Self-administered Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Self-administered Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Self-administered Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Self-administered Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Self-administered Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Self-administered Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Self-administered Drugs Market Segments
Table 2. Ranking of Global Top Self-administered Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Self-administered Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Injectable Drugs
Table 5. Major Manufacturers of Inhaled Drugs
Table 6. Major Manufacturers of Transdermal Drugs
Table 7. Global Self-administered Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Self-administered Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Self-administered Drugs Sales by Regions 2015-2020 (K MT)
Table 10. Global Self-administered Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Self-administered Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Self-administered Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Self-administered Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Self-administered Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Self-administered Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Self-administered Drugs as of 2019)
Table 16. Self-administered Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Self-administered Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Self-administered Drugs Price (2015-2020) (USD/MT)
Table 19. Self-administered Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Self-administered Drugs Product Type
Table 21. Date of International Manufacturers Enter into Self-administered Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 24. Global Self-administered Drugs Sales Share by Type (2015-2020)
Table 25. Global Self-administered Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Self-administered Drugs Revenue Share by Type (2015-2020)
Table 27. Self-administered Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 29. Global Self-administered Drugs Sales Share by Application (2015-2020)
Table 30. North America Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 31. North America Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 35. North America Self-administered Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 37. North America Self-administered Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 39. Europe Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 43. Europe Self-administered Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 45. Europe Self-administered Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Self-administered Drugs Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Self-administered Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Self-administered Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Self-administered Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Self-administered Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Self-administered Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 55. Latin America Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 59. Latin America Self-administered Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 61. Latin America Self-administered Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Self-administered Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Self-administered Drugs Sales Market Share by Application (2015-2020)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Major Businesses
Table 72. Abbott Laboratories Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Abbott Laboratories Product
Table 74. Abbott Laboratories Recent Development
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Major Businesses
Table 82. Novartis AG Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis AG Product
Table 84. Novartis AG Recent Development
Table 85. Eli Lilly and Company Corporation Information
Table 86. Eli Lilly and Company Description and Major Businesses
Table 87. Eli Lilly and Company Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Eli Lilly and Company Product
Table 89. Eli Lilly and Company Recent Development
Table 90. Gilead Sciences Corporation Information
Table 91. Gilead Sciences Description and Major Businesses
Table 92. Gilead Sciences Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Gilead Sciences Product
Table 94. Gilead Sciences Recent Development
Table 95. Antares Pharma Corporation Information
Table 96. Antares Pharma Description and Major Businesses
Table 97. Antares Pharma Self-administered Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Antares Pharma Product
Table 99. Antares Pharma Recent Development
Table 100. Global Self-administered Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 101. Global Self-administered Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Self-administered Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Self-administered Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Self-administered Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 105. North America: Self-administered Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Self-administered Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 107. Europe: Self-administered Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Self-administered Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 109. Asia Pacific: Self-administered Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Self-administered Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 111. Latin America: Self-administered Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Self-administered Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 113. Middle East and Africa: Self-administered Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Self-administered Drugs Players
Table 118. Self-administered Drugs Customers List
Table 119. Self-administered Drugs Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Self-administered Drugs Product Picture
Figure 2. Global Self-administered Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Injectable Drugs Product Picture
Figure 4. Inhaled Drugs Product Picture
Figure 5. Transdermal Drugs Product Picture
Figure 6. Global Self-administered Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Cardiovascular Diseases
Figure 8. Diabetes
Figure 9. Osteoporosis
Figure 10. Pain Management
Figure 11. Hormone Replacement
Figure 12. Others
Figure 13. Self-administered Drugs Report Years Considered
Figure 14. Global Self-administered Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Self-administered Drugs Sales 2015-2026 (K MT)
Figure 16. Global Self-administered Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Self-administered Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Self-administered Drugs Sales Market Share by Region in 2019
Figure 19. Global Self-administered Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Self-administered Drugs Revenue Market Share by Region in 2019
Figure 21. Global Self-administered Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Self-administered Drugs Revenue in 2019
Figure 23. Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Self-administered Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Self-administered Drugs Sales Market Share by Type in 2019
Figure 26. Global Self-administered Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Self-administered Drugs Revenue Market Share by Type in 2019
Figure 28. Global Self-administered Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Self-administered Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Self-administered Drugs Sales Market Share by Application in 2019
Figure 31. Global Self-administered Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Self-administered Drugs Revenue Market Share by Application in 2019
Figure 33. North America Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Self-administered Drugs Sales Market Share by Country in 2019
Figure 36. North America Self-administered Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Self-administered Drugs Market Share by Type in 2019
Figure 42. North America Self-administered Drugs Market Share by Application in 2019
Figure 43. Europe Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Self-administered Drugs Sales Market Share by Country in 2019
Figure 46. Europe Self-administered Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Self-administered Drugs Market Share by Type in 2019
Figure 58. Europe Self-administered Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Self-administered Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Self-administered Drugs Revenue Market Share by Region in 2019
Figure 63. China Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Self-administered Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Self-administered Drugs Market Share by Application in 2019
Figure 87. Latin America Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Self-administered Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Self-administered Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Self-administered Drugs Market Share by Type in 2019
Figure 98. Latin America Self-administered Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Self-administered Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Self-administered Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Self-administered Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Self-administered Drugs Market Share by Application in 2019
Figure 111. North America Self-administered Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. North America Self-administered Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Self-administered Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Europe Self-administered Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Self-administered Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Asia Pacific Self-administered Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Self-administered Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Latin America Self-administered Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Self-administered Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Middle East and Africa Self-administered Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…- 結膜炎治療薬の世界市場（～2026年） Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in …
- 注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…